Difficulty: Medium
Average Score: 84%
Practice
Five patients are seen by their primary care physician because of chronic anxiety. Benzodiazepines are being considered for each of the patients. Which of the following patients would be best suited for this medication?
Correct answer
C
Rationale
In this scenario, the correct answer is option C, the 36-year-old man with gastroesophageal reflux disorder, as the best candidate for benzodiazepine therapy.
Benzodiazepines are central nervous system (CNS) depressants commonly used to treat anxiety disorders due to their anxiolytic properties. However, they can have potential risks and side effects, especially in certain patient populations. Option A, the pregnant woman, is not an ideal candidate due to the potential risks to the developing fetus, including teratogenic effects and withdrawal symptoms in the newborn.
Option B, the woman with alcoholic liver disease and HIV, poses a risk of drug interactions and exacerbation of liver disease due to the metabolism of benzodiazepines in the liver. Option D, the man with alcoholic liver disease, also presents similar risks of liver metabolism issues and potential exacerbation of his liver condition.
Educationally, it is essential to consider the physiological differences and comorbidities of patients when selecting medications. Understanding the pharmacokinetics and pharmacodynamics of drugs in different patient populations is crucial to providing safe and effective care. In this case, the patient with gastroesophageal reflux disorder would likely have fewer contraindications and risks associated with benzodiazepine therapy compared to the other options, making him the most suitable candidate in this scenario.
Benzodiazepines are central nervous system (CNS) depressants commonly used to treat anxiety disorders due to their anxiolytic properties. However, they can have potential risks and side effects, especially in certain patient populations. Option A, the pregnant woman, is not an ideal candidate due to the potential risks to the developing fetus, including teratogenic effects and withdrawal symptoms in the newborn.
Option B, the woman with alcoholic liver disease and HIV, poses a risk of drug interactions and exacerbation of liver disease due to the metabolism of benzodiazepines in the liver. Option D, the man with alcoholic liver disease, also presents similar risks of liver metabolism issues and potential exacerbation of his liver condition.
Educationally, it is essential to consider the physiological differences and comorbidities of patients when selecting medications. Understanding the pharmacokinetics and pharmacodynamics of drugs in different patient populations is crucial to providing safe and effective care. In this case, the patient with gastroesophageal reflux disorder would likely have fewer contraindications and risks associated with benzodiazepine therapy compared to the other options, making him the most suitable candidate in this scenario.